FDA Issues Draft Guidance on Managing Cybersecurity Risks AffectingAI-Enabled Devices
The National Law Review The Food and Drug Administration's new draft guidance outlines cybersecurityrisksforAI-enabled medical devices and recommends lifecycle …
Read the original at The National Law Review ↗
- Topics
- CybersecurityHealthcareRegulation & Policy
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”